Zydus Pharmaceuticals UK Ltd
Registered name: ZYDUS PHARMACEUTICALS UK LTD
Zydus Pharmaceuticals UK Ltd made £5.6m revenue and a £2.8m loss in the year to 31 Mar 2024.
Zydus Pharmaceuticals UK Ltd’s revenue was £5.6m in the year to 31 Mar 2024, with a loss of £2.8m and 3 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Bristol; we hold 2 years of its filed accounts.
- Status
- Active
- Location
- Bristol, South West
- Age
- 3 yrs · since 2023
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 7 Feb 2023 | 31 Mar 2024 |
|---|---|---|
| Disclosure | No P&L | Full P&L |
| Profit & loss | ||
| Revenue (turnover) | — | £5.6m |
| Cost of sales | — | £993k |
| Gross profit | — | £4.6m |
| Operating profit | — | −£2.9m |
| Profit before tax | — | −£5.2m |
| Profit after tax | — | −£2.8m |
| Profit (best available) | — | −£2.8m |
| Staff costs | — | £155k |
| Employees (average) | — | 3 |
| Ratios | ||
| Profit margin | — | −49.3% |
| Gross margin | — | 82.3% |
| Revenue per employee | — | £1.9m |
| Profit per employee | — | −£919k |
| Balance sheet — indirect signals, not revenue | ||
| Cash at bank | £0 | £795k |
| Net assets | — | £67.1m |
| Fixed assets | £2.5m | £145m |
| Current assets | — | £24m |
| Debtors | — | £0 |
| Deferred income | — | £5.9k |
| Cash from operations | — | −£826k |
| Source | FullAccounts · bulk data Mar 2025 | FullAccounts · bulk data Mar 2025 |
How the business works
- Profit margin
- −49.3%
- Profit ÷ revenue.
- Gross margin
- 82.3%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £1.9m
- Revenue ÷ average employees.
- Profit per employee
- −£919k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 2586%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 0.1%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 0%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now £67.1m
- Cash at bank
- —
- Now £795k
- Headcount
- —
- Now 3
- Deferred income
- —
- Now £5.9k
- Fixed assets
- —
- Now £145m
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Subsidiaries (5)
- L M Manufacturing LimitedFigures not disclosed
- Liqmeds Lifecare LimitedFigures not disclosed
- Liqmeds LimitedFigures not disclosed
- Liqmeds Worldwide LimitedFigures not disclosed
- Medsolutions (Europe) LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Abacus Medicine Pharma Services LtdFarnborough · Wholesale of pharmaceutical goods
- Revenue
- £6.3m
- Profit
- £348k
- Staff
- 21
- Recordati Rare Diseases UK LimitedMaidenhead · Wholesale of pharmaceutical goods
- Revenue
- £6.4m
- Profit
- £123k
- Staff
- 9
- Apellis UK LimitedLondon · Wholesale of pharmaceutical goods
- Revenue
- £4.7m
- Profit
- £127k
- Staff
- 11
- Ananta Medicare LtdFulham London · Wholesale of pharmaceutical goods
- Revenue
- £4.7m
- Profit
- £90.9k
- Staff
- 3
- Arena Pharmaceuticals LimitedBuckingham · Wholesale of pharmaceutical goods
- Revenue
- £4.5m
- Profit
- £394k
- Staff
- 3
- Itf Pharma LtdLondon · Wholesale of pharmaceutical goods
- Revenue
- £3.6m
- Profit
- £320k
- Staff
- 9
Sources
Latest figures from FullAccounts for the year to 31 Mar 2024 (profit −£2.8m), from the Companies House accounts bulk data published Mar 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.